Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13,838,977
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
6,220,826
-
Shares change
-
+52,381
-
Total reported value, excl. options
-
$49,800,000
-
Value change
-
+$418,571
-
Number of buys
-
6
-
Number of sells
-
-6
-
Price
-
$8
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q2 2022
29 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q2 2022.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,220,826 shares
of 13,838,977 outstanding shares and own 44.95% of the company stock.
Largest 10 shareholders include Battery Management Corp. (2,421,673 shares), NEA Management Company, LLC (1,713,720 shares), Millrace Asset Group, Inc. (354,041 shares), VANGUARD GROUP INC (345,843 shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (286,611 shares), RENAISSANCE TECHNOLOGIES LLC (164,346 shares), BlackRock Inc. (123,359 shares), ESSEX INVESTMENT MANAGEMENT CO LLC (115,075 shares), DIMENSIONAL FUND ADVISORS LP (113,343 shares), and AMERIPRISE FINANCIAL INC (84,177 shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.